Health Expectations (Dec 2022)

Pilot trial of iBDecide: Evaluating an online tool to facilitate shared decision making for adolescents and young adults with ulcerative colitis

  • Kelly A. Matula,
  • Philip Minar,
  • Nancy M. Daraiseh,
  • Li Lin,
  • Marlee Recker,
  • Ellen A. Lipstein

DOI
https://doi.org/10.1111/hex.13618
Journal volume & issue
Vol. 25, no. 6
pp. 3105 – 3113

Abstract

Read online

Abstract Introduction This pilot, randomized controlled trial aimed to evaluate the usability, among adolescents and young adults (AYAs) with ulcerative colitis (UC), of a web‐based tool (‘iBDecide’) designed to facilitate shared decision making (SDM). Methods AYAs with UC (n = 35) were randomized to intervention (iBDecide, n = 14) and control (n = 12) arms before a scheduled clinic visit. We measured the usability of iBDecide, SDM, preferred decision‐making style, decision conflict and intervention use. Results Participants in the intervention group found iBDecide easy to use and agreed that it made them feel ready to participate in decision making and that they would use it to prepare for appointments. There were 130 visits to iBDecide, lasting on average 3 min, 41 s. The medication and nutrition trackers were among the most‐viewed pages. Pages specifically designed to facilitate SDM were viewed only four times. Across groups, too few participants reported making decisions during clinic visits for decision‐related measures to be reported. Conclusions This pilot trial provides evidence for the usability of iBDecide and guidance for developing a larger‐scale trial of a combined web‐based and in‐clinic SDM intervention. Overall, iBDecide shows promise in engaging AYAs with UC in SDM and condition management. Patient or Public Contribution Patients, specifically AYAs with UC, and healthcare providers were involved in the design of this study's intervention, iBDecide. Additionally, the research team, from study conception to manuscript writing, included a young adult with inflammatory bowel disease. Clinical Trial Registration: This study was registered at clinicaltrials.gov (NCT04207008).

Keywords